Agila Specialties

Agila Specialties Recalls Etomidate Injection

Agila Specialties Recalls Etomidate Injection

Mylan Inc. subsidiary Agila Specialties has initiated nationwide recall of Etomidate injection manufactured at pharmaceutical facility in Warsaw, Poland. The company first informed about the recall on February 13.

The injections have possibility of containing small black particles. The intravenous administration of Etomidate could lead to infection, embolism or phlebitis. The injections are used for the induction of general anesthesia. The injections were marketed by Pfizer.


Popular Stories

Uber’s net loss declines as ride bookings grow

Uber Technologies reported lower loss by nearly 9... Read More

Samsung Galaxy Note 8 facing challenges on multiple fronts

The Samsung Galaxy Note 8 is facing an increasingly... Read More

Leaked reports reveal more about new BMW M5

Luxury carmaker BMW’s next-generation M5 car will... Read More

Tesla announces risky new approach to customer service

During the past few years, Tesla was slammed by a... Read More

Facebook downranks video clickbait & fake play buttons

Facebook, the world’s most-popular social-... Read More